HUTCHMED (China) (HCM) Cash & Equivalents: 2014-2025

Historic Revenue - Interest and Investment Income for HUTCHMED (China) (HCM) over the last 2 years, with Jun 2025 value amounting to $1.8 billion.

  • HUTCHMED (China)'s Revenue - Interest and Investment Income rose 40.85% to $1.8 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $5.4 billion, marking a year-over-year increase of 12.16%. This contributed to the annual value of $1.4 billion for FY2021, which is 89.56% up from last year.
  • As of Q2 2025, HUTCHMED (China)'s Cash & Equivalents stood at -$46.0 million, which was up 40.92% from -$77.8 million recorded in Q2 2024.
  • In the past 5 years, HUTCHMED (China)'s Cash & Equivalents ranged from a high of $587.4 million in Q2 2021 and a low of -$83.7 million during Q2 2023.
  • In the last 3 years, HUTCHMED (China)'s Cash & Equivalents had a median value of -$77.8 million in 2024 and averaged -$69.2 million.
  • Per our database at Business Quant, HUTCHMED (China)'s Revenue - Interest and Investment Income soared by 142.20% in 2021 and then fell by 25.00% in 2022.
  • Quarterly analysis of 5 years shows HUTCHMED (China)'s Revenue - Interest and Investment Income stood at $1.4 billion in 2021, then dropped by 25.00% to $1.0 billion in 2022, then climbed by 8.64% to $1.3 billion in 2023, then declined by 2.82% to $1.3 billion in 2024, then surged by 40.85% to $1.8 billion in 2025.
  • Its Revenue - Interest and Investment Income stands at $1.8 billion for Q2 2025, versus $1.3 billion for Q2 2024 and $1.3 billion for Q2 2023.